Article Text

Download PDFPDF
Pre-discharge stress echocardiography and exercise ECG for risk stratification after uncomplicated acute myocardial infarction: results of the COSTAMI-II (cost of strategies after myocardial infarction) trial
  1. A Desideri1,
  2. P M Fioretti2,
  3. L Cortigiani3,
  4. G Trocino4,
  5. C Astarita5,
  6. D Gregori2,
  7. J Bax6,
  8. J Velasco7,
  9. L Celegon1,
  10. R Bigi1,
  11. S Pirelli8,
  12. E Picano9
  1. 1Cardiovascular Research Foundation, S Giacomo Hospital, Castelfranco Veneto, Italy
  2. 2IRCAB Foundation, S Maria della Misericordia Hospital, Udine, Italy
  3. 3Cardiology Department, Campo di Marte Hospital, Lucca, Italy
  4. 4Cardiology Department, S Gerardo Hospital, Monza, Italy
  5. 5Cardiology Department, Sorrento General Hospital, Sorrento, Italy
  6. 6University Medical Centre, Leiden, the Netherlands
  7. 7Cardiology Department, University General Hospital, Valencia, Spain
  8. 8Cardiology Department, General Hospital, Cremona, Italy
  9. 9CNR Institute of Clinical Physiology, Pisa, Italy
  1. Correspondence to:
    Dr Alessandro Desideri
    Cardiovascular Research Foundation, S Giacomo Hospital, 31033 Castelfranco Veneto, Italy; aldesitin.it

Abstract

Objective: To compare in a prospective, randomised, multicentre trial the relative merits of pre-discharge exercise ECG and early pharmacological stress echocardiography concerning risk stratification and costs of treating patients with uncomplicated acute myocardial infarction.

Design: 262 patients from six participating centres with a recent uncomplicated myocardial infarction were randomly assigned to early (day 3–5) pharmacological stress echocardiography (n  =  132) or conventional pre-discharge (day 7–9) maximum symptom limited exercise ECG (n  =  130).

Results: No complication occurred during either stress echocardiography or exercise ECG. At one year follow up there were 26 events (1 death, 5 non-fatal reinfarctions, 20 patients with unstable angina requiring hospitalisation) in patients randomly assigned to early stress echocardiography and 18 events (2 reinfarctions, 16 unstable angina requiring hospitalisation) in the group randomly assigned to exercise ECG (not significant). The negative predictive value was 92% for stress echocardiography and 88% for exercise ECG (not significant). Total costs of the two strategies were similar (not significant).

Conclusion: Early pharmacological stress echocardiography and conventional pre-discharge symptom limited exercise ECG have similar clinical outcome and costs after uncomplicated infarction. Early pharmacological stress echocardiography should be considered a valid alternative even for patients with interpretable baseline ECG who can exercise.

  • AMI, acute myocardial infarction
  • CABG, coronary artery bypass graft
  • COSTAMI-II, cost of strategies after myocardial infarction
  • DANAMI, Danish trial in acute myocardial infarction
  • EDIC, Echo Dobutamine International Cooperative
  • EPIC, Echo Persantine International Cooperative
  • PTCA, percutaneous transluminal coronary angioplasty
  • myocardial infarction
  • risk stratification
  • cost–benefit analysis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes